Brent Pfeiffenberger - Mar 7, 2024 Form 4/A Insider Report for Butterfly Network, Inc. (BFLY)

Role
President and CEO, Director
Signature
/s/ Douglas Carr, Attorney-in-Fact
Stock symbol
BFLY
Transactions as of
Mar 7, 2024
Transactions value $
$0
Form type
4/A
Date filed
5/24/2024, 05:14 PM
Date Of Original Report
Mar 11, 2024
Previous filing
Dec 6, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % Price $ Shares After Date Ownership Footnotes
holding BFLY Common Stock 0 Mar 7, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding BFLY Stock Option (right to buy) 0 Mar 7, 2024 Common Stock Direct F1

Explanation of Responses:

Id Content
F1 This Form 4 Amendment is being filed to correct the original Form 4. The original Form 4 was filed erroneously with an incorrect Issuer. The Reporting Person has no affiliation nor does he own any shares of Butterfly Network, Inc. The Reporting Person is the President and CEO of Century Therapeutics, Inc. and a correct Form 4 has been filed.